Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMT
3801
Aberdeen Multi-Market Income Fund
MMT
$240M
| $129K | ﹤0.01% |
27,513
+5,161
| +23% | +$23.6K |
|
3802
Cornerstone Strategic Value Fund
CLM
$2.23B
| $129K | ﹤0.01% |
15,916
-255
| -2% | -$1.88K |
|
3803
MacroGenics
MGNX
$248M
| $127K | ﹤0.01% |
104,751
+52,326
| +100% | +$75.9K |
|
3804
Rockwell Medical
RMTI
$28.7M
| $126K | ﹤0.01% |
14,830
-9
| -0.1% | -$92 |
|
3805
Enanta Pharmaceuticals
ENTA
$384M
| $126K | ﹤0.01% |
16,624
-18,749
| -53% | -$113K |
|
3806
Opko Health
OPK
$1.01B
| $125K | ﹤0.01% |
94,760
+669
| +0.7% | +$915 |
|
|
HPP
3807
Hudson Pacific Properties
HPP
$812M
| $123K | ﹤0.01% |
6,406
-170
| -3% | -$2.76K |
|
3808
Atea Pharmaceuticals
AVIR
$380M
| $122K | ﹤0.01% |
33,751
| – | – |
|
3809
Novavax
NVAX
$1.27B
| $120K | ﹤0.01% |
19,090
-12,656
| -40% | -$83.8K |
|
3810
Invesco Pennsylvania Value Municipal Income Trust
VPV
$195M
| $119K | ﹤0.01% |
11,822
| – | – |
|
|
CRF
3811
Cornerstone Total Return Fund
CRF
$1.16B
| $115K | ﹤0.01% |
14,854
-297
| -2% | -$2.11K |
|
3812
Sibanye-Stillwater
SBSW
$7.02B
| $115K | ﹤0.01% |
15,918
+2,874
| +22% | +$15.7K |
|
3813
Intellia Therapeutics
NTLA
$1.53B
| $111K | ﹤0.01% |
11,803
+1,443
| +14% | +$11.8K |
|
3814
Weibo
WB
$1.95B
| $109K | ﹤0.01% |
11,461
-3,402
| -23% | -$29.9K |
|
|
PMX
3815
DELISTED
PIMCO Municipal Income Fund III
PMX
| $109K | ﹤0.01% |
15,831
+3,004
| +23% | +$20.5K |
|
|
ELEV
3816
DELISTED
Elevation Oncology
ELEV
| $108K | ﹤0.01% |
294,326
-4,464
| -1% | -$1.49K |
|
3817
Zentalis Pharmaceuticals
ZNTL
$352M
| $106K | ﹤0.01% |
91,195
+78,578
| +623% | +$104K |
|
|
LAR
3818
Lithium Argentina AG
LAR
$1.04B
| $105K | ﹤0.01% |
50,443
-3,594
| -7% | -$7.16K |
|
3819
1-800-Flowers.com
FLWS
$265M
| $104K | ﹤0.01% |
21,214
-673,996
| -97% | -$3.49M |
|
|
SAND
3820
DELISTED
Sandstorm Gold
SAND
| $103K | ﹤0.01% |
10,995
-659
| -6% | -$5.64K |
|
3821
Smith & Wesson
SWBI
$658M
| $101K | ﹤0.01% |
+11,620
| New | +$110K |
|
3822
Aldeyra Therapeutics
ALDX
$96.5M
| $101K | ﹤0.01% |
+26,263
| New | +$67.9K |
|
|
BTA
3823
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $101K | ﹤0.01% |
+10,968
| New | +$100K |
|
|
ZH
3824
Zhihu
ZH
$282M
| $99.5K | ﹤0.01% |
+25,006
| New | +$97K |
|
|
MAV
3825
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $97.9K | ﹤0.01% |
11,791
-85
| -0.7% | -$697 |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.